Anna Sárközy

10.1k total citations
91 papers, 2.9k citations indexed

About

Anna Sárközy is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Anna Sárközy has authored 91 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 22 papers in Cardiology and Cardiovascular Medicine and 18 papers in Immunology. Recurrent topics in Anna Sárközy's work include Muscle Physiology and Disorders (27 papers), Protein Tyrosine Phosphatases (20 papers) and Cardiomyopathy and Myosin Studies (19 papers). Anna Sárközy is often cited by papers focused on Muscle Physiology and Disorders (27 papers), Protein Tyrosine Phosphatases (20 papers) and Cardiomyopathy and Myosin Studies (19 papers). Anna Sárközy collaborates with scholars based in United Kingdom, Italy and United States. Anna Sárközy's co-authors include Bruno Dallapiccola, M. Cristina Digilio, Bruno Marino, Antonio Pizzuti, Rita Mingarelli, Emanuela Conti, Tania Dottorini, Giuseppe Limongelli, Francesco Muntoni and Andrea De Zorzi and has published in prestigious journals such as Neurology, CHEST Journal and The American Journal of Human Genetics.

In The Last Decade

Anna Sárközy

86 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Sárközy United Kingdom 30 2.4k 787 510 503 449 91 2.9k
Tetsuya Niihori Japan 27 1.8k 0.8× 659 0.8× 146 0.3× 164 0.3× 495 1.1× 78 2.9k
Edward C. Hsiao United States 29 1.7k 0.7× 442 0.6× 207 0.4× 123 0.2× 363 0.8× 100 3.8k
Corey K. Goldman United States 21 2.0k 0.9× 179 0.2× 228 0.4× 406 0.8× 395 0.9× 35 3.5k
Paul Grossfeld United States 22 1.7k 0.7× 178 0.2× 893 1.8× 756 1.5× 716 1.6× 53 2.9k
Franca Casagranda Australia 12 1.2k 0.5× 575 0.7× 99 0.2× 204 0.4× 143 0.3× 26 2.3k
Elias T. Zambidis United States 29 2.2k 1.0× 394 0.5× 89 0.2× 148 0.3× 213 0.5× 61 3.3k
Bruno Leheup France 29 1.1k 0.5× 238 0.3× 89 0.2× 145 0.3× 758 1.7× 97 2.2k
Minna Pöyhönen Finland 31 865 0.4× 249 0.3× 489 1.0× 50 0.1× 260 0.6× 76 3.7k
Thomas D. Arnold United States 20 661 0.3× 295 0.4× 230 0.5× 76 0.2× 110 0.2× 30 2.0k
Douglas J. Wilkin United States 22 1.4k 0.6× 109 0.1× 380 0.7× 105 0.2× 1.1k 2.5× 29 2.7k

Countries citing papers authored by Anna Sárközy

Since Specialization
Citations

This map shows the geographic impact of Anna Sárközy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sárközy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sárközy more than expected).

Fields of papers citing papers by Anna Sárközy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Sárközy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sárközy. The network helps show where Anna Sárközy may publish in the future.

Co-authorship network of co-authors of Anna Sárközy

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Sárközy. A scholar is included among the top collaborators of Anna Sárközy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Sárközy. Anna Sárközy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sárközy, Anna, Filip Van Petegem, Michael F. Goldberg, et al.. (2024). Individuals and Families Affected by RYR1-Related Diseases: The Patient/Caregiver Perspective. Journal of Neuromuscular Diseases. 11(5). 1067–1083. 1 indexed citations
2.
Ridout, Deborah, et al.. (2024). Relationship between growth and ambulation loss in Duchenne muscular dystrophy boys on steroids. European Journal of Neurology. 31(12). e16415–e16415. 3 indexed citations
3.
James, M., Michela Guglieri, Adnan Manzur, et al.. (2024). Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data. European Journal of Paediatric Neurology. 53. 123–130. 2 indexed citations
4.
Sárközy, Anna, Mário Sá, Deborah Ridout, et al.. (2023). Long-term Natural History of Pediatric Dominant and Recessive RYR1 -Related Myopathy. Neurology. 101(15). e1495–e1508. 4 indexed citations
5.
Sárközy, Anna, et al.. (2022). Early clinical and pre-clinical therapy development in Nemaline myopathy. Expert Opinion on Therapeutic Targets. 26(10). 853–867. 9 indexed citations
6.
Field, Ella, Helen Walsh, Gabrielle Norrish, et al.. (2022). Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort. Frontiers in Pediatrics. 10. 910660–910660. 5 indexed citations
7.
Nicolau, Stefan, Joshua J. Todd, Filip Van Petegem, et al.. (2022). RYR-1-Related Diseases International Research Workshop: From Mechanisms to Treatments Pittsburgh, PA, U.S.A., 21-22 July 2022. Journal of Neuromuscular Diseases. 10(1). 135–154. 7 indexed citations
8.
Wadman, Renske I., Ramona De Amicis, Alberto Battezzati, et al.. (2020). Feeding difficulties in children and adolescents with spinal muscular atrophy type 2. Neuromuscular Disorders. 31(2). 101–112. 16 indexed citations
9.
Ullmann, Urielle, L. D'Argenzio, Shrey Mathur, et al.. (2018). ECEL1 gene related contractural syndrome: Long-term follow-up and update on clinical and pathological aspects. Neuromuscular Disorders. 28(9). 741–749. 10 indexed citations
10.
Brunklaus, Andreas, S. Robb, Rosaline C. M. Quinlivan, et al.. (2016). Vitamin D in corticosteroid-naïve and corticosteroid-treated Duchenne muscular dystrophy: what dose achieves optimal 25(OH) vitamin D levels?. Archives of Disease in Childhood. 101(10). 957–961. 11 indexed citations
11.
Cruz, Pedro M. Rodríguez, Katsiaryna Belaya, Keivan Basiri, et al.. (2016). Clinical features of the myasthenic syndrome arising from mutations in GMPPB. Journal of Neurology Neurosurgery & Psychiatry. 87(8). 802–809. 44 indexed citations
12.
Limongelli, Giuseppe, Raffaella D‘Alessandro, Valeria Maddaloni, et al.. (2013). Skeletal muscle involvement in cardiomyopathies. Journal of Cardiovascular Medicine. 14(12). 837–861. 17 indexed citations
13.
Guida, Valentina, Rosangela Ferese, Marcella Rocchetti, et al.. (2012). A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of Fallot. European Journal of Human Genetics. 21(1). 69–75. 35 indexed citations
14.
Wagner, Matias, Amina Chaouch, Juliane Müller, et al.. (2012). Presymptomatic late-onset Pompe disease identified by the dried blood spot test. Neuromuscular Disorders. 23(1). 89–92. 8 indexed citations
15.
Luca, Alessandro De, Anna Sárközy, Federica Consoli, et al.. (2009). Familial transposition of the great arteries caused by multiple mutations in laterality genes. Heart. 96(9). 673–677. 85 indexed citations
16.
Digilio, M. Cristina, Flaminia Calzolari, Rossella Capolino, et al.. (2008). Congenital heart defects in patients with oculo‐auriculo‐vertebral spectrum (Goldenhar syndrome). American Journal of Medical Genetics Part A. 146A(14). 1815–1819. 35 indexed citations
17.
Sárközy, Anna, Annalisa Schirinzi, Francesca Romana Lepri, et al.. (2007). Clinical lumping and molecular splitting of LEOPARD and NF1/NF1‐Noonan syndromes. American Journal of Medical Genetics Part A. 143A(9). 1009–1011. 9 indexed citations
18.
Sárközy, Anna, et al.. (2006). Noonan's syndrome and related disorders: Clinical-molecular update and guidelines. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 32(3). 145–155. 3 indexed citations
19.
Sárközy, Anna, Emanuela Conti, M. Cristina Digilio, et al.. (2005). ZFPM2/FOG2 andHEY2 genes analysis in nonsyndromic tricuspid atresia. American Journal of Medical Genetics Part A. 133A(1). 68–70. 11 indexed citations
20.
Sárközy, Anna, Eugenia Conti, Christian Néri, et al.. (2005). Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. Journal of Medical Genetics. 42(2). e16–e16. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tetsuya Niihori Breakdown of academic impact, for papers by Edward C. Hsiao Breakdown of academic impact, for papers by Corey K. Goldman Breakdown of academic impact, for papers by Paul Grossfeld Breakdown of academic impact, for papers by Franca Casagranda Breakdown of academic impact, for papers by Elias T. Zambidis Breakdown of academic impact, for papers by Bruno Leheup Breakdown of academic impact, for papers by Minna Pöyhönen Breakdown of academic impact, for papers by Thomas D. Arnold Breakdown of academic impact, for papers by Douglas J. Wilkin
Rankless by CCL
2026